Comparison of Pain in Different Quadrants while giving Intravitreal Injection
DOI:
https://doi.org/10.52206/jsmc.2022.12.4.737Abstract
Background: Intravitreal injection is most popular universal intraocular procedure. it is important to consider the discomfort related with this procedure in order to ensure patient compliance and safety.
Objective: To compare the pain in different quadrants correlated to intrvitreal bevacizumab injection.
Material and Methods: Randomized controlled trial of four months was done In-patient Ophthalmology department, Pakistan Institute of Medical Sciences (PIMS) Islamabad between May-2020 to Sep-2020.In this study 120 patients were included (30 patients in each group) to measure the extent of pain while receiving an intravitreal bevacizumab injection. Sample size was calculated by WHO sample size calculator with 5% Level of significance, 80% Power of test.The data analyzed by using SPSS 23.
Results: The results of pain score in our study showed that the mean pain score of the patients in Group A Superonasal Quadrant was 1.50 ± 0.51, in Group B Superotemporal Quadrant was 4.00 ± 0.91, in Group C Inferonasal Quadrant was 2.70 ± 0.84 and in Group D Inferotemporal Quadrant was 2.87 ± 0.78. The results of p value showed significant difference in pain score in groups. The Pain score is less in Group A Superonasal Quadrant as 1.50 ± 0.51 and more in Group B Superotemporal Quadrant as 4.00 ± 0.91.
Conclusion: Superonasal Quadrant (SN Quadrant) was the less pain site as compared to others site i.e. Superotemporal Quadrant (ST quadrant), Inferonasal Quadrant (IN
Quadrant) and Inferotemporal Quadrant (IT Quadrant). The most pain full site was Superotemporal Quadrant (ST quadrant).
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 The authors retain the copyrights. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website), as it can lead to productive exchanges, as well as greater citation of published work.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.